B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
1 clinical trials · Condition
◉ Watch B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT02819804) | Northwestern University | 2017-08-17 |
Track B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 automatically
Every clearance here is in the API, with alerts when new ones post.